Smith & Nephew plc (LON:SN) shares were up 1.4% on Monday . The company traded as high as GBX 1,325 ($17.83) and last traded at GBX 1,316 ($17.71). Approximately 2,776,018 shares were traded during mid-day trading, a decline of 4% from the average daily volume of 2,890,000 shares. The stock had previously closed at GBX 1,298 ($17.47).
A number of analysts have commented on the stock. Deutsche Bank reiterated a “buy” rating on shares of Smith & Nephew in a research note on Friday, October 13th. Jefferies Group reiterated a “buy” rating and issued a GBX 1,515 ($20.39) price target on shares of Smith & Nephew in a research note on Thursday, October 12th. Berenberg Bank reiterated a “hold” rating and issued a GBX 1,340 ($18.03) price target on shares of Smith & Nephew in a research note on Friday, November 3rd. J P Morgan Chase & Co cut their price target on shares of Smith & Nephew from GBX 1,382 ($18.60) to GBX 1,369 ($18.43) and set a “neutral” rating for the company in a research note on Monday, November 13th. Finally, Goldman Sachs Group reiterated a “neutral” rating and issued a GBX 1,380 ($18.57) price target on shares of Smith & Nephew in a research note on Monday, September 11th. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and two have issued a buy rating to the company’s stock. Smith & Nephew presently has a consensus rating of “Hold” and a consensus target price of GBX 1,315.82 ($17.71).
COPYRIGHT VIOLATION WARNING: This article was first published by Week Herald and is the sole property of of Week Herald. If you are reading this article on another site, it was stolen and reposted in violation of U.S. and international trademark and copyright legislation. The legal version of this article can be viewed at https://weekherald.com/2017/12/04/smith-nephew-sn-trading-up-1-4.html.
About Smith & Nephew
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.
Receive News & Ratings for Smith & Nephew plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew plc and related companies with MarketBeat.com's FREE daily email newsletter.